Multiparameter Immunochromatographic Assay Detects and Differentiates Hepatitis C Antibodies
By LabMedica International staff writers
Posted on 14 Aug 2013
A hepatitis C (HCV) rapid test has been developed that should provide additional information about the infection profile.Posted on 14 Aug 2013
The Multisure HCV antibody assay is a qualitative, multiparameter, immunochromatographic assay, intended for the detection and differentiation of Hepatitis C antibodies that may be present in patients with acute or chronic Hepatitis C infection. The test was developed based on the patented reverse-flow technology, giving greater sensitivity and stronger visual signals.
Developed by MP Diagnostic (Solon, OH, USA), the Multisure HCV antibody assay uses human whole blood, plasma, or serum. It has a short test-time and can detect and differentiate HCV antibodies against both structural and non-structural proteins across all six genotypes. The assay is instrument free, easy to use, and is suitable for use at Point-of-Care (POC) or with automation. It does not require highly trained personnel to perform the test. It has shown excellent correlation with polymerase chain reaction (PCR), enzyme immunoassay (EIA), and Immunoblot.
MP Biomedicals received the CE marking for its new, multiparameter Hepatitis C test.
Related Links:
MP Diagnostic
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Hematology Consumables
Bioblood Devices
